Linda T. Vo

2.1k total citations · 1 hit paper
21 papers, 1.2k citations indexed

About

Linda T. Vo is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Linda T. Vo has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cell Biology and 4 papers in Physiology. Recurrent topics in Linda T. Vo's work include CRISPR and Genetic Engineering (6 papers), Zebrafish Biomedical Research Applications (5 papers) and Erythrocyte Function and Pathophysiology (4 papers). Linda T. Vo is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), Zebrafish Biomedical Research Applications (5 papers) and Erythrocyte Function and Pathophysiology (4 papers). Linda T. Vo collaborates with scholars based in United States, Germany and Brazil. Linda T. Vo's co-authors include Jeffrey A. Bluestone, Caroline Raffin, George Q. Daley, Sergei Doulatov, James J. Collins, Leonard I. Zon, Brandon Hadland, Stephanie Chou, Natasha Arora and Hu Li and has published in prestigious journals such as Nature, Blood and Nature reviews. Immunology.

In The Last Decade

Linda T. Vo

19 papers receiving 1.2k citations

Hit Papers

Treg cell-based therapies: challenges and perspectives 2019 2026 2021 2023 2019 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda T. Vo United States 10 622 444 285 169 162 21 1.2k
Mania Ackermann Germany 19 684 1.1× 412 0.9× 180 0.6× 71 0.4× 195 1.2× 37 1.1k
Andrew Sprague United States 13 421 0.7× 745 1.7× 209 0.7× 81 0.5× 150 0.9× 17 1.4k
Greg Parsonage United Kingdom 14 516 0.8× 613 1.4× 404 1.4× 78 0.5× 65 0.4× 17 1.5k
Shirly Becker-Herman Israel 21 373 0.6× 1.2k 2.7× 277 1.0× 144 0.9× 135 0.8× 33 1.7k
Elena Tanghetti Italy 16 810 1.3× 287 0.6× 233 0.8× 266 1.6× 95 0.6× 23 1.3k
Takahiro Ueda Japan 17 621 1.0× 216 0.5× 175 0.6× 133 0.8× 143 0.9× 51 1.2k
Yoko K. Takada United States 21 543 0.9× 223 0.5× 209 0.7× 148 0.9× 73 0.5× 35 1.0k
Nicolas Goudin France 15 517 0.8× 538 1.2× 104 0.4× 116 0.7× 106 0.7× 29 1.0k
Sorin Armeanu Germany 19 880 1.4× 403 0.9× 289 1.0× 61 0.4× 227 1.4× 38 1.4k
Evelyne Lauret France 19 610 1.0× 352 0.8× 222 0.8× 77 0.5× 125 0.8× 49 1.2k

Countries citing papers authored by Linda T. Vo

Since Specialization
Citations

This map shows the geographic impact of Linda T. Vo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda T. Vo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda T. Vo more than expected).

Fields of papers citing papers by Linda T. Vo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda T. Vo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda T. Vo. The network helps show where Linda T. Vo may publish in the future.

Co-authorship network of co-authors of Linda T. Vo

This figure shows the co-authorship network connecting the top 25 collaborators of Linda T. Vo. A scholar is included among the top collaborators of Linda T. Vo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda T. Vo. Linda T. Vo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinney, Melissa A., Martha A. Clark, Linda T. Vo, et al.. (2025). A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs. Experimental Hematology. 152. 105264–105264.
2.
Stahl, Elizabeth C., Jennifer K. Sabo, Min Hyung Kang, et al.. (2023). Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs. Molecular Therapy. 31(8). 2422–2438. 22 indexed citations
3.
Vo, Linda T., et al.. (2023). Use of apixaban in children awaiting heart transplantation. Pediatric Transplantation. 28(1). e14632–e14632. 3 indexed citations
4.
Leavens, Karla F., Juan R. Alvarez‐Dominguez, Linda T. Vo, Holger A. Russ, & Audrey V. Parent. (2022). Stem cell-based multi-tissue platforms to model human autoimmune diabetes. Molecular Metabolism. 66. 101610–101610. 12 indexed citations
5.
Osborne, Jihan K., Melissa A. Kinney, Areum Han, et al.. (2021). Lin28 paralogs regulate lung branching morphogenesis. Cell Reports. 36(3). 109408–109408. 4 indexed citations
6.
Neef, Vanessa, Linda T. Vo, Eva Herrmann, et al.. (2021). The association between intraoperative cell salvage and red blood cell transfusion in cardiac surgery – an observational study in a patient blood management centre. Anaesthesiology Intensive Therapy. 53(1). 1–9. 4 indexed citations
7.
Kinney, Melissa A., Linda T. Vo, Jenna M. Frame, et al.. (2019). A systems biology pipeline identifies regulatory networks for stem cell engineering. Nature Biotechnology. 37(7). 810–818. 18 indexed citations
8.
Nguyen, David N., Theodore L. Roth, P. Jonathan Li, et al.. (2019). Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency. Nature Biotechnology. 38(1). 44–49. 194 indexed citations
9.
Raffin, Caroline, Linda T. Vo, & Jeffrey A. Bluestone. (2019). Treg cell-based therapies: challenges and perspectives. Nature reviews. Immunology. 20(3). 158–172. 501 indexed citations breakdown →
10.
Rocha, Edroaldo Lummertz da, Linda T. Vo, Jenna M. Frame, et al.. (2019). Ezh1 Inhibits Commitment to Hemogenic Fate and HSPC Formation during Vertebrate Development. Blood. 134(Supplement_1). 3710–3710. 1 indexed citations
11.
Vo, Linda T., Melissa A. Kinney, Xin Liu, et al.. (2018). Regulation of embryonic haematopoietic multipotency by EZH1. Nature. 553(7689). 506–510. 61 indexed citations
12.
Daley, George Q., Linda T. Vo, Sergei Doulatov, & George Q. Daley. (2018). Haematopoietic progenitor and lymphoid differentiation from human pluripotent stem cells. Protocol Exchange. 1 indexed citations
13.
Kinney, Melissa A., et al.. (2017). Enucleation and Beta-Globin Expression in Induced Red Blood Cells: A Platform to Model Sickle Cell Anemia. Blood. 130. 538–538. 2 indexed citations
14.
Vo, Linda T.. (2016). Reflections on the Formation and Future of Asian American Studies. eScholarship (California Digital Library). 14(2). 117–128. 1 indexed citations
15.
Ruiz‐Gutierrez, Melisa, Özge Vargel Bölükbaşı, Linda T. Vo, et al.. (2016). Modeling Bone Marrow Failure and MDS in Shwachman Diamond Syndrome Using Induced Pluripotent Stem Cells. Blood. 128(22). 1496–1496. 1 indexed citations
16.
Doulatov, Sergei, Linda T. Vo, Elizabeth R. Macari, et al.. (2016). Drug discovery using induced pluripotent stem cells identifies autophagy as a therapeutic pathway for anemia. Experimental Hematology. 44(9). S48–S48. 1 indexed citations
17.
Cortes, Mauricio, David L. Stachura, Sarah Y. Liu, et al.. (2016). Developmental Vitamin D Availability Impacts Hematopoietic Stem Cell Production. Cell Reports. 17(2). 458–468. 94 indexed citations
18.
Doulatov, Sergei, Linda T. Vo, Elizabeth R. Macari, et al.. (2014). Modeling Diamond Blackfan Anemia in Vivo Using Human Induced Pluripotent Stem Cells. Blood. 124(21). 359–359. 1 indexed citations
19.
Doulatov, Sergei, Linda T. Vo, Stephanie Chou, et al.. (2013). Induction of Multipotential Hematopoietic Progenitors from Human Pluripotent Stem Cells via Respecification of Lineage-Restricted Precursors. Cell stem cell. 13(4). 459–470. 199 indexed citations
20.
Oh, Joong‐Hwan, et al.. (2003). Contemporary Asian American Communities: Intersections and Divergences. Contemporary Sociology A Journal of Reviews. 32(6). 736–736. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026